|
Salukhov V.V., Shustov S.B., Petrankov K.V.
Advantages of combined use of sodium-glucose co-transporter type 2 inhibitors and glucagon-like peptide-1 receptor agonists relatively to cardiovascular and renal outcomes in patients with type 2 diabetes mellitus
|
№8 / 2024
|
|
Katushkina Yu.A., Tatarintseva Z.G., Kosmacheva E.D.
A case of severe euglycemic ketoacidosis arising during dapagliflozin intake
|
№6 / 2024
|
|
Teltevskaya I.I., Ivanova S.V., Yushchuk E.N., Mkrtumyan A.M., Melekhina I.V.
Shock wave therapy: Possibilities and perspectives for application in clinical practice for diabetic foot patients
|
№4 / 2024
|
|
Lagutina S.N., Pashkova A.A., Dudurich V.V., Danilov L.G., Ermachenko E.D.
Diagnostical value of intestinal microbiota as one of the leading factors of the development of ulcerative colitis in type 2 diabetes mellitus patients
|
№3 / 2024
|
|
Yuzhakova E.V., Smirnova E.N.
Experience of dapagliflozin use in elderly female patients with hyperactive urinary bladder
|
№1 / 2024
|
|
Demidova T.Yu., Ushanova F.O.
The role and place of dipeptidyl peptidase-4 inhibitors in modern approaches to the management of type 2 diabetes mellitus
|
№9 / 2023
|
|
Larina V.N., Lankin A.O., Larin V.G., Golovko M.G.
Modern viewpoint at prediabetes: Prevalence, diagnostic criteria, risk groups, screening
|
№9 / 2023
|
|
Demicheva T.P.
Relationship of depressive and eating disorders, quality of life in women with complicated type 2 diabetes mellitus
|
№9 / 2023
|
|
Teplova, A.S. Demidova T.Yu., Lobanova K.G.
Peculiarities of outpatient glycemic profile of patients with type 2 diabetes mellitus during innovative sugar-reducing therapy combined with metformin according to flash glucose monitoring data
|
№9 / 2023
|
|
Demidova T.Yu., Izmaylova M.Ya., Antsiferov M.B.
Possibilities of early diagnosis of chronic heart failure and chronic kidney disease in patients with type 2 diabetes mellitus at the hospital stage
|
№9 / 2023
|
|
Skuridina D.V., Demidova T.Yu.
Clinical and metabolic peculiarities in male patients with type 2 diabetes mellitus and hypogonadism
|
№9 / 2023
|
|
Usanova A.A., Lavrenova E.A., Kunyaeva T.A., Kuzma F., Novikova E.K., Sergutova N.P., Chatkina T.A.
Modern aspects of use of tirzepatide – the first dual agonist of glucagon-like peptide-1 and glucosependent insulinotropic peptide receptors
|
№8 / 2023
|
Русский
